Trials / Unknown
UnknownNCT05567822
The Impact of Esmolol Administration on Postoperative Recovery
The Effect of Intraoperative Esmolol Administration on Postoperative Recovery and Chronic Pain
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Aretaieion University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain
Detailed description
Contemporary anaesthesiology requires the quest of ways to restrict the use of opioids, which aim at the alleviation of severe postoperative and chronic pain. This is not only due to the side effects involved but also to the epidemic dimensions their use entails. Esmolol, an extremely short-acting cardioselective antagonist of β1 adrenergic receptors, is effectively used in order to attenuate the stress response and minimize undesirable perioperative hemodynamic changes. More specifically, esmolol has been used effectively to reduce pain during induction of anesthesia with propofol and treat tachycardia and hypertension during laryngoscopy. However, recent studies also highlight a possible antinociceptive and/or analgesic effect of esmolol. Therefore, The aim of this study will be to investigate the effect of a continuous infusion of low dose esmolol on intraoperative and postoperative opioid consumption, as well as on postoperative recovery and chronic pain
Conditions
- Pain, Acute
- Pain, Postoperative
- Pain, Chronic Post-Surgical
- Esmolol
- Inguinal Hernia Repair
- Analgesia
- Nociceptive Pain
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esmolol Hydrochloride | In the esmolol group, patients will receive a bolus dose of esmolol followed by a continuous infusion of esmolol intraoperatively |
| DRUG | normal saline | In the placebo group, patients will receive a bolus dose of normal saline followed by a continuous infusion of normal saline intraoperatively |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2024-10-01
- Completion
- 2024-10-01
- First posted
- 2022-10-05
- Last updated
- 2022-10-27
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT05567822. Inclusion in this directory is not an endorsement.